Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Lab &
The peptide preserved retinal morphological structure, intensified bioelectric activity, and improved functional capacity of photoreceptor cells
What this means for access Until PCAC recommends and FDA acts, neither compound is approved for compounding under 503A as a Category 1 substance
As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants
US$ 23.27
US$ 29.48
.png.jpg)
US$ 27.56
